9-121822637-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001139442.2(TTLL11):c.2083C>T(p.Arg695Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,506,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001139442.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL11 | NM_001139442.2 | c.2083C>T | p.Arg695Cys | missense_variant | 9/9 | ENST00000321582.11 | NP_001132914.2 | |
TTLL11 | NM_001386833.1 | c.430C>T | p.Arg144Cys | missense_variant | 4/4 | NP_001373762.1 | ||
TTLL11 | XM_047422825.1 | c.1507C>T | p.Arg503Cys | missense_variant | 8/8 | XP_047278781.1 | ||
TTLL11 | XR_001746188.2 | n.2243C>T | non_coding_transcript_exon_variant | 9/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL11 | ENST00000321582.11 | c.2083C>T | p.Arg695Cys | missense_variant | 9/9 | 5 | NM_001139442.2 | ENSP00000321346.6 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000258 AC: 3AN: 116076Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 60672
GnomAD4 exome AF: 0.0000103 AC: 14AN: 1354514Hom.: 0 Cov.: 32 AF XY: 0.00000753 AC XY: 5AN XY: 664054
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74476
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at